We are live on ! Find out more
First Manhattan

First Manhattan Portfolio holdings

AUM $36.1B
1-Year Est. Return 11.5%
This Fund
S&P 500
This Quarter Est. Return
-3.36%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$23.6B
AUM Growth
-$1.2B
Cap. Flow
-$152M
Cap. Flow %
-0.64%
Top 10 Hldgs %
59.63%
Holding
1,742
New
84
Increased
209
Reduced
452
Closed
104

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$117M
2
ENTG icon
Entegris
ENTG
+$107M
3
TFX icon
Teleflex
TFX
+$26.6M
4
NKE icon
Nike
NKE
+$25.8M
5
SPGI icon
S&P Global
SPGI
+$20.9M

Sector Composition

Rank Sector Weight
1 Financials 43.69%
2 Technology 15.09%
3 Healthcare 11.64%
4 Consumer Discretionary 8.73%
5 Communication Services 5.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNAP icon
1276
Snap
SNAP
$7.32B
$6K ﹤0.01%
625
SPEM icon
1277
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$17B
$6K ﹤0.01%
209
-39
-16% -$1.33K
TDOC icon
1278
Teladoc Health
TDOC
$1.58B
$6K ﹤0.01%
266
+80
+43% +$2.81K
THO icon
1279
Thor Industries
THO
$3.99B
$6K ﹤0.01%
100
VST icon
1280
Vistra
VST
$55.1B
$6K ﹤0.01%
300
XLRE icon
1281
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.69B
$6K ﹤0.01%
193
UMPQ
1282
DELISTED
Umpqua Holdings Corp
UMPQ
$6K ﹤0.01%
355
AKRO
1283
DELISTED
Akero Therapeutics
AKRO
$5K ﹤0.01%
150
AQB icon
1284
AquaBounty Technologies
AQB
$4.68M
$5K ﹤0.01%
356
BDN
1285
Brandywine Realty Trust
BDN
$551M
$5K ﹤0.01%
780
BMRN icon
1286
BioMarin Pharmaceuticals
BMRN
$11.5B
$5K ﹤0.01%
60
BYND icon
1287
Beyond Meat
BYND
$288M
$5K ﹤0.01%
395
EDIT icon
1288
Editas Medicine
EDIT
$399M
$5K ﹤0.01%
443
FDS icon
1289
Factset
FDS
$9.05B
$5K ﹤0.01%
13
GIB icon
1290
CGI
GIB
$13.9B
$5K ﹤0.01%
72
IEP icon
1291
Icahn Enterprises
IEP
$5.17B
$5K ﹤0.01%
113
HAPN
1292
Happen Inc
HAPN
$2.08B
$5K ﹤0.01%
526
LDTC
1293
DELISTED
LeddarTech
LDTC
$5K ﹤0.01%
1,200
MATV icon
1294
Mativ Holdings
MATV
$448M
$5K ﹤0.01%
+271
New +$6.2K
MRAM icon
1295
Everspin Technologies
MRAM
$354M
$5K ﹤0.01%
1,000
NQP
1296
DELISTED
Nuveen Pennsylvania Quality Municipal Income Fund
NQP
$5K ﹤0.01%
525
NTLA icon
1297
Intellia Therapeutics
NTLA
$1.5B
$5K ﹤0.01%
105
NXJ
1298
DELISTED
Nuveen New Jersey Quality Municipal Income Fund
NXJ
$5K ﹤0.01%
500
OPTN
1299
DELISTED
OptiNose
OPTN
$5K ﹤0.01%
100
-67
-40% -$3.68K
RELX icon
1300
RELX
RELX
$60.1B
$5K ﹤0.01%
227

Similar funds

First Manhattan's Q3 2022 Portfolio in Review

As of Q3 2022, First Manhattan held 1,742 positions worth $23.6B, down 4.8% from $24.8B the previous quarter. Its ten largest holdings account for 60% of the portfolio.

First Manhattan's Q3 2022 filing shows 84 new, 209 increased, 452 reduced and 104 closed positions. Its largest new stake was Element Solutions: 151,800 shares worth $2.47M. The largest sale was Apple, an estimated $59.9M.

By sector, the portfolio is most concentrated in Financials at 44% of assets, up from 43% a quarter earlier, followed by Technology and Healthcare.

  • First Manhattan's largest Q3 2022 buy was Element Solutions: 151,800 shares worth $2.47M.
  • First Manhattan added most to Linde in Q3 2022, an estimated $117M increase.
  • First Manhattan's biggest Q3 2022 reduction was Apple, cutting an estimated $59.9M.
  • First Manhattan fully exited Blueprint Medicines in Q3 2022, selling an estimated $29.7M.
  • First Manhattan's ten largest holdings make up 60% of its $23.6B portfolio in Q3 2022.
  • First Manhattan opened 84 new positions and closed 104 in Q3 2022.
  • First Manhattan's portfolio value fell 4.8% quarter-over-quarter to $23.6B.

Based on First Manhattan's 13F filing for Q3 2022, filed 14 Nov 2022.